The projects listed below were advertised in the Spring 2024 round of recruitment, which has now closed. New projects will be advertised when we open the next call for fellowship applications, in Spring 2025.
Principal Investigator |
Project Title |
Prof Nicola Smart, Associate Prof Gillian Douglas, Prof Kim Dora, Dr Nils Rorsman1 |
A multi-omic 'meta-analysis' of the smooth muscle phenotypic transition in vascular disease to identify disease-promoting mechanisms, prognostic biomarkers and therapeutic targets. |
Prof Molly Stevens, Prof Paul Riley, Prof Georg Holländer 2 |
Engineering human cardiac organoids at scale to accelerate in vitro cardiovascular research |
Dr Sally Cowley, Dr Kevin Gonzales1 |
Human induced pluripotent stem cell-derived microglial systems of the hypothalamus for high-throughput target discovery in obesity |
Prof Angela Russell, Dr Jorge Correia1 |
Ligand-directed two-step labelling: a new technology to map the trafficking and interactome of GLUT4 |
Prof Philip Torr, Associate Prof Jesper Ferkinghoff-Borg1, Dr Robert Kitchen1, Dr Cesar Medina1
|
Navigating the genetic perturbation landscape: Multi-modal, causal representation learning for target discovery.
|
Dr Ioannis Akoumianakis, Prof Charalambos Antoniades 2 |
Reprograming insulin signalling in the human cardiovascular system
|
Prof Zameel Cader, Prof Laura Parkkinen, Prof David Ray, Dr Robert Kitchen1, Dr Cesar Medina1
|
Single cell biology of the human hypothalamus in obesity and hypertension
|
Prof David Ray, Prof Stuart Peirson, Prof Aiden Doherty, Prof David Hodson, Dr Wei Gan1
|
Sleep and circadian regulation of cardiometabolic disease
|
Prof Shoumo Bhattacharya, Associate Prof Gillian Douglas, Prof Claudia Monaco, Dr Luke Payne1, Dr Nils Rorsman1
|
Targeting the chemokine network in metabolic inflammation
|
Prof Claudia Monaco, Dr Lea Dib, Prof Ashok Handa, Dr Luke Payne1, Dr Giorgio Caratti1, Dr Charlotte Daly1, Dr Alexey Epanchintsev1
|
Targeting the transition to inflammatory lipid-associated macrophages in CVD
|
1 supervisor from Novo Nordisk Denmark or Novo Nordisk Research Centre Oxford
2 A scientist from Novo Nordisk will be assigned as a mentor to this project